J Uro FDA Drug Safety Communication: 5-alpha reductase inhibitors (5-ARIs) may increase the risk of a more serious form of prostate cancer
BPC157 is not intended for human or veterinary administration Research Use Only Notice This product is intended for laboratory research use only and is not approved for human or veterinary use
Effervescent and liquid forms may absorb more quickly than standard capsules, potentially offering faster performance-related benefits
For the entire group, the median vitamin B12 level before treatment was 328 (range, 244429) pmol/l, and 973 (range, 4761476) pmol/l after treatment
Taken together, our results suggested that the OCCT may serve as a robust tool to identify TMAO-generating phenotypes from carnitine metabolism and to explore relevant microbiome signatures in humans
(ii) Insulin-lowering drugs such as metformin and diazoxide provide another opportunity for improving cancer outcome in patients